XML 111 R89.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED INCENTIVE PLANS - UNVESTED CASH AND STOCK-SETTLED RSUs, TSRIs & CROCEI (Details) - $ / shares
shares in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash-Settled RSUs      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 298    
Granted (in shares) 131    
Vested (in shares) (148)    
Forfeitures (in shares) (10)    
Unvested, end of period (in shares) 271 298  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 37.96    
Granted, weighted-average grant-date fair value (in dollars per share) 60.43 $ 47.41 $ 25.83
Vested, weighted-average grant-date fair value (in dollars per share) 36.33    
Forfeitures, weighted-average grant-date fair value (in dollars per share) 42.19    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 49.53 $ 37.96  
Stock-Settled RSUs      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 8,894    
Granted (in shares) 3,342    
Vested (in shares) (4,330)    
Forfeitures (in shares) (174)    
Unvested, end of period (in shares) 7,732 8,894  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 36.70    
Granted, weighted-average grant-date fair value (in dollars per share) 59.85 $ 45.14 $ 25.45
Vested, weighted-average grant-date fair value (in dollars per share) 35.81    
Forfeitures, weighted-average grant-date fair value (in dollars per share) 44.37    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 47.03 $ 36.70  
TSRIs      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 1,643    
Granted (in shares) 459    
Vested (in shares) (591)    
Forfeitures (in shares) (4)    
Unvested, end of period (in shares) 1,507 1,643  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 35.51    
Granted, weighted-average grant-date fair value (in dollars per share) 59.71    
Vested, weighted-average grant-date fair value (in dollars per share) 41.60    
Forfeitures, weighted-average grant-date fair value (in dollars per share) 59.71    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 40.43 $ 35.51  
Payout at vesting percentage 122.00%    
Issued (in shares) 721    
CROCEI awards      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 574    
Granted (in shares) 130    
Vested (in shares) (197)    
Unvested, end of period (in shares) 507 574  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 35.73    
Granted, weighted-average grant-date fair value (in dollars per share) 59.71    
Vested, weighted-average grant-date fair value (in dollars per share) 41.60    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 39.59 $ 35.73  
Payout at vesting percentage 200.00%    
Issued (in shares) 395